Peripheral Vascular Devices | Market Insights | Asia Pacific (Supplemental) | 2023
Following the short-term negative impact of the COVID-19 pandemic on the Asia Pacific PV device market, the high prevalence of PAD in the region, an expanding patient population, growth in endovascular procedure volumes, and rising adoption of premium-priced devices such as DCBs and DES will support continued growth in the Asia Pacific PV device market; however, cost constraints in the region’s publicly funded healthcare systems and limited reimbursement continue to hinder adoption of premium-priced devices and limit the pace of revenue expansion.
This Medtech 360 Report provides high-level market metrics for PV devices in Asia Pacific, including country-level data for major countries and aggregate data for the rest of Asia Pacific from 2019 through 2031.
